MIME-Version: 1.0
Content-Location: file:///C:/9E8BDD12/2009-9-17Newsletter.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="us-ascii"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dus-ascii">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 11">
<meta name=3DOriginator content=3D"Microsoft Word 11">
<link rel=3DFile-List href=3D"2009-9-17Newsletter_files/filelist.xml">
<title>Ladies and gentlemen,</title>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"place"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"City"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"country-region"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"stockticker"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"PlaceName"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"PlaceType"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"State"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author> </o:Author>
  <o:LastAuthor>BARBARA</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>68</o:TotalTime>
  <o:Created>2009-09-17T23:48:00Z</o:Created>
  <o:LastSaved>2009-09-17T23:48:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>697</o:Words>
  <o:Characters>3974</o:Characters>
  <o:Company> </o:Company>
  <o:Lines>33</o:Lines>
  <o:Paragraphs>9</o:Paragraphs>
  <o:CharactersWithSpaces>4662</o:CharactersWithSpaces>
  <o:Version>11.9999</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" LatentStyleCount=3D"156">
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid=3D"clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=3Dieooui></objec=
t>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147476737 14699 0 0 63 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:windowtext;}
h1
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:14.0pt;
	font-family:"Times New Roman";
	color:windowtext;
	font-weight:bold;}
h2
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	font-size:18.0pt;
	font-family:"Times New Roman";
	color:#666666;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
strong
	{font-family:"Lucida Sans Unicode";
	mso-ascii-font-family:"Lucida Sans Unicode";
	mso-hansi-font-family:"Lucida Sans Unicode";
	mso-bidi-font-family:"Lucida Sans Unicode";}
p
	{mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:9.5pt;
	font-family:Verdana;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:black;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple style=3D'tab-interval:.5in'>

<div class=3DSection1>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:9.5p=
t;
font-family:Arial;mso-bidi-font-family:"Times New Roman";color:#999999'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'>17 September 2009<o:p></o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'mso-bidi-font-size:14.0pt;font-family:Arial'>President Obama annou=
nces
US will donate 10% of its 2009 H1N1 pandemic flu vaccine (non-adjuvanted) <=
span
style=3D'mso-spacerun:yes'>&nbsp;</span>to WHO for other nations, as WHO Di=
rector
Dr. Margaret Chan sees devastating impact of the pandemic virus in some cou=
ntries<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'>Today the White House posted a press release on their
website stating that the <st1:country-region w:st=3D"on"><st1:place w:st=3D=
"on">US</st1:place></st1:country-region>
will donate 10% of its 2009 H1N1 pandemic flu vaccine, on a rolling basis as
the vaccine becomes available, to the World Health Organization (WHO) for
distribution to nations &#8220;that will not otherwise have direct access to
the vaccine&#8221;. The <st1:country-region w:st=3D"on"><st1:place w:st=3D"=
on">US</st1:place></st1:country-region>
is joining at least eight (8) other nations in donating vaccine to the WHO.
These nations (in alphabetical order) are: <st1:country-region w:st=3D"on">=
Australia</st1:country-region>,
<st1:country-region w:st=3D"on">Brazil</st1:country-region>, <st1:country-r=
egion
w:st=3D"on">France</st1:country-region>, <st1:country-region w:st=3D"on">It=
aly</st1:country-region>,
<st1:country-region w:st=3D"on">New Zealand</st1:country-region>, <st1:coun=
try-region
w:st=3D"on">Norway</st1:country-region>, <st1:country-region w:st=3D"on">Sw=
itzerland</st1:country-region>,
and the <st1:country-region w:st=3D"on"><st1:place w:st=3D"on">UK</st1:plac=
e></st1:country-region>.
Additional nations were invited to join these nine countries as vaccine bec=
omes
available more widely in the months ahead.<o:p></o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span style=3D'font-size:9.0pt;mso-bidi-font-size:1=
4.0pt;
font-family:Arial'>None</span></u><span style=3D'font-size:9.0pt;mso-bidi-f=
ont-size:
14.0pt;font-family:Arial'> of the four <st1:country-region w:st=3D"on"><st1=
:place
 w:st=3D"on">US</st1:place></st1:country-region> pandemic vaccines licensed=
 by
the Food and Drug Administration (FDA) on September 15 contain any vaccine
adjuvant. <span class=3DGramE>Specifically, none of the <st1:country-region
w:st=3D"on"><st1:place w:st=3D"on">US</st1:place></st1:country-region> pand=
emic
vaccines containing any MF-59, squalene, or any other adjuvant.</span> The =
four
vaccines licensed this week by the FDA are made by: Sanofi, MedImmune, <st1=
:stockticker
w:st=3D"on">CSL</st1:stockticker>, and Novartis.<span
style=3D'mso-spacerun:yes'>&nbsp; </span>(Some confusion may have arisen am=
ong
some health care workers and some members of the general population regardi=
ng pandemic
vaccine adjuvant because Novartis also has an MF-59 adjuvanted pandemic
2009<span style=3D'mso-spacerun:yes'>&nbsp; </span>H1N1 vaccine about which=
 they
reported a clinical study online September 10<sup>th</sup> in the New Engla=
nd
Journal of Medicine). The FDA-licensed Novartis pandemic flu vaccine, howev=
er,
is a NON-adjuvanted vaccine.<o:p></o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'>President Obama&#8217;s announcement today is particular=
ly
timely. Two days ago (September 15), the Director-General of the World Heal=
th
Organization (WHO) Dr. Margaret Chan made the following poignant statement =
on her
view of the likely impact of the influenza pandemic in some developing nati=
ons,
during her address in Denmark to the Regional Committee for Europe:<o:p></o=
:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'>&#8220;To date, we have been fortunate in the way the
pandemic has evolved. The overwhelming majority of cases continue to experi=
ence
mild symptoms and recover fully within a week, even without any medical
treatment</span><span style=3D'font-size:9.0pt;mso-bidi-font-size:12.0pt;
font-family:Arial;mso-bidi-font-family:"Times New Roman"'>.<o:p></o:p></spa=
n></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>But
clinically, this is a virus of extremes. It does not seem to have a middle
ground. At one extreme are the mild cases. At the other extreme is a small
subset of patients who quickly develop very severe disease.<o:p></o:p></spa=
n></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Though
the numbers are small, the demands on health services are disproportionately
high. Saving these lives depends on highly specialized intensive care, with
highly specialized equipment and highly skilled staff. In countries that la=
ck
such capacities, these lives will be at great danger. <o:p></o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Of
course, this is true for a multitude of other diseases and health problems.
Weak capacities cost lives. But this pandemic, I believe, will make the same
old point in an especially visible and tragic manner. <o:p></o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>I
believe that this pandemic will be a watershed event. It is taking place at=
 a
time when differences, within and between countries, in income levels, in
health status, and in levels of care, are greater than at any time in recent
history. The pandemic will test the world on the issue of fairness in a
substantial way. <o:p></o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>The
same virus that causes manageable disruption in affluent countries will alm=
ost
certainly have a devastating impact in countries with too few health facili=
ties
and staff, no regular supplies of essential medicines, little diagnostic and
laboratory capacity, and vast populations with no access to safe water and
sanitation. For these populations, advice such as wash your hands, call your
doctor, or rush to the emergency ward will mean very little. <o:p></o:p></s=
pan></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Let
me give just one precise example. We know, from all outbreak sites, that
pregnant women are at increased risk of severe or fatal infections. Increas=
ed
deaths of these women, because of the pandemic, will be tragic everywhere, =
but
most especially so in the developing world, as the numbers will be so much
greater.&#8221;<o:p></o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'><o:p>&nbsp;</o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Taken
together, the above statement by Dr. Margaret Chan of the WHO and the
announcement by President Obama will hopefully serve as a precedent not only
for protection against pandemic influenza by vaccines now, but for enhanced
international protection against other vaccine-preventable infectious disea=
ses
in the near-term future.<o:p></o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'><o:p>&nbsp;</o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Daniel
R. Lucey, MD, <st1:stockticker w:st=3D"on">MPH</st1:stockticker><o:p></o:p>=
</span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>EROne
Institute, Department of Emergency Medicine<o:p></o:p></span></p>

<p><st1:place w:st=3D"on"><st1:PlaceName w:st=3D"on"><span style=3D'font-si=
ze:9.0pt;
  mso-bidi-font-size:14.0pt;font-family:Arial'>Washington</span></st1:Place=
Name><span
 style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Arial'> <st=
1:PlaceType
 w:st=3D"on">Hospital</st1:PlaceType> <st1:PlaceType w:st=3D"on">Center</st=
1:PlaceType></span></st1:place><span
style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Arial'><o:p>=
</o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Adjunct
Professor, Department of Microbiology and Immunology<o:p></o:p></span></p>

<p><st1:place w:st=3D"on"><st1:City w:st=3D"on"><span style=3D'font-size:9.=
0pt;
  mso-bidi-font-size:14.0pt;font-family:Arial'>Georgetown University Medical
  Center</span></st1:City><span style=3D'font-size:9.0pt;mso-bidi-font-size=
:14.0pt;
 font-family:Arial'>, <st1:State w:st=3D"on">Washington</st1:State></span><=
/st1:place><span
style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Arial'>, DC<=
o:p></o:p></span></p>

<p><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0pt;font-family:Ari=
al'>Website
for this posting: <a href=3D"http://www.bepast.org/">www.BePast.org</a> (re=
quires
IE)<o:p></o:p></span></p>

<p class=3DMsoNormal><span style=3D'font-size:9.0pt;mso-bidi-font-size:14.0=
pt;
font-family:Arial'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
